International Clinical Trial: A Study on the Efficacy of a Vaccine Against Influenza in Adults =65 Years of Age

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805707) titled 'A Study on the Efficacy of a Vaccine Against Influenza in Adults =65 Years of Age' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: GlaxoSmithKline

Condition: Influenza, Human

Intervention: Combination Product: mRNA Seasonal Flu vaccine

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 2, 2026

Target Sample Size: 54000

To know more, visit https://clinicaltrials.gov/study/N...